CG ONCOLOGY INC (CGON)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CGON
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CGON | Director | 53 | ["Senior Advisor and Entrepreneur in Residence at Locust Walk Partners, LLC since May 2021","Former Chief Executive Officer of Akamara Therapeutics from August 2019 to May 2021","Former Chief Business Officer at Epizyme from April 2016 to September 2018","Former Principal Financial Officer at Epizyme from August 2017 to September 2018","Held Vice President position at NPS Pharma before acquisition by Shire in 2015","Nearly 18 years at Roche in leadership and executive positions","Chaired audit committee of Finch Therapeutics from April 2021 through March 2024","Board Chair at Finch Therapeutics from April 2022 through March 2024","Chaired audit committee of Aardvark Therapeutics since November 2024","Board member of Kaléo since December 2021","M.B.A. from the Stern School of Business at New York University","B.Pharm. from Purdue University"] | ["Audit Committee (Chair)","Nominating and Corporate Governance Committee","Audit Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Susan Graf serves as Chair of the Audit Committee and serves on the Nominating and Corporate Governance Committee.